home > epc

European Pharmaceutical Contractor


European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.


For further information please contact:

Jonathan Smith

Charlie Burgon

We're also on Twitter! Follow us @EPCmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

View the digital version of EPC


Featured in this issue
Legal & Regulatory
Intellectual Property

Expiry Date

Pharmaceutical marketing increasingly requires a long-term proposal, as Tina Rees-Pedlar at Marks & Clerk points out. With a solid plan in place, businesses can gain revenue from their products long past the patent expiry date.
Legal & Regulatory
Vulnerable Populations

Patient Protection

Investigators' main priority should be ensuring the safety of patients, especially those in vulnerable populations. Theorem Clinical Research's Marc Hoffman summarises the stringent measures required to guard those who are most at risk.


  Regional Focus
Clinical Research: Turkey

Land of Opportunity

At the centre of an emerging region, Turkey boasts a supportive regulatory framework, a large number of sites and diverse patients, and a competive cost structure. Ömer Sadun Okyaltırık and Yamin Khan of Pharm-Olam report.

Edited by
Dr Graham Hughes,
Consultant in
Published quarterly in
March, June,
September and December
Banner of Medical Research Network (MRN) Limited on Samedan
Banner of ESMO.EPC on Samedan
Banner of Cool chain.EPC on Samedan
Industry Events

Analytical Method Development, Validation and Transfer

15-16 September 2015, Maritim proArte Hotel Berlin, Germany

Informa Life Sciences' 5th Annual Analytical Method Development, Validation and Transfer is a dedicated forum focusing on industry case studies, regulatory agency feedback and interactive formats to enable increased speed and efficiency.
More info >>

News and Press Releases

Call For Abstracts

The 5th Munich Biomarker Conference on 1st-2nd December 2015 is the place to be to get a spotlight on Personalized Medicine!
More info >>

Banner of Drug Delivery Congress on Samedan
air transport logo


White Papers

Convergence in the Pharmaceutical Market

Packaging Coordinators, Inc.

Convergence is currently playing a large part in the growth of the pharmaceutical market. The need for convergence is due to many factors including the declining economy and high competition within the sector. There are many convergences within this sector to date; these include the convergence of food based products with medical and health products and the convergence of prescription drugs to over the counter (OTC) products. Although convergence is helping the pharmaceutical industry expand and develop, it also poses some challenges; these include the regulatory outlook and counterfeiting.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement